Cargando…
The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541732/ https://www.ncbi.nlm.nih.gov/pubmed/37772698 http://dx.doi.org/10.1177/17539447231202933 |
| _version_ | 1785113960673968128 |
|---|---|
| author | Ashinze, Patrick Abdul-Rahman, Toufik Wireko, Andrew Awuah |
| author_facet | Ashinze, Patrick Abdul-Rahman, Toufik Wireko, Andrew Awuah |
| author_sort | Ashinze, Patrick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10541732 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105417322023-10-02 The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure Ashinze, Patrick Abdul-Rahman, Toufik Wireko, Andrew Awuah Ther Adv Cardiovasc Dis Letter to the Editor SAGE Publications 2023-09-29 /pmc/articles/PMC10541732/ /pubmed/37772698 http://dx.doi.org/10.1177/17539447231202933 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Ashinze, Patrick Abdul-Rahman, Toufik Wireko, Andrew Awuah The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| title | The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| title_full | The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| title_fullStr | The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| title_full_unstemmed | The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| title_short | The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| title_sort | usage of sglt-2 inhibitors in the management of heart failure in rural africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541732/ https://www.ncbi.nlm.nih.gov/pubmed/37772698 http://dx.doi.org/10.1177/17539447231202933 |
| work_keys_str_mv | AT ashinzepatrick theusageofsglt2inhibitorsinthemanagementofheartfailureinruralafricamitigatingthebarrierstotheoptimaladoptionofanoveladjuvanttherapeuticagentinthemanagementofheartfailure AT abdulrahmantoufik theusageofsglt2inhibitorsinthemanagementofheartfailureinruralafricamitigatingthebarrierstotheoptimaladoptionofanoveladjuvanttherapeuticagentinthemanagementofheartfailure AT wirekoandrewawuah theusageofsglt2inhibitorsinthemanagementofheartfailureinruralafricamitigatingthebarrierstotheoptimaladoptionofanoveladjuvanttherapeuticagentinthemanagementofheartfailure AT ashinzepatrick usageofsglt2inhibitorsinthemanagementofheartfailureinruralafricamitigatingthebarrierstotheoptimaladoptionofanoveladjuvanttherapeuticagentinthemanagementofheartfailure AT abdulrahmantoufik usageofsglt2inhibitorsinthemanagementofheartfailureinruralafricamitigatingthebarrierstotheoptimaladoptionofanoveladjuvanttherapeuticagentinthemanagementofheartfailure AT wirekoandrewawuah usageofsglt2inhibitorsinthemanagementofheartfailureinruralafricamitigatingthebarrierstotheoptimaladoptionofanoveladjuvanttherapeuticagentinthemanagementofheartfailure |